专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070026502A1 Specificity exchangers that redirect antibodies to a pathogen 审中-公开
标题翻译：将抗体重定向到病原体的特异性交换剂
公开(公告)号：US20070026502A1
公开(公告)日：2007-02-01
申请号：US11412181
申请日：2006-04-26
申请人： Matti Sallberg , Jan-Ingmar Flock
发明人： Matti Sallberg , Jan-Ingmar Flock
IPC分类号： C12P19/34
摘要： Specificity exchangers and methods of making and using specificity exchangers are disclosed. Specificity exchangers are useful for preventing and treating human diseases including cancer and those resulting from pathogens such as bacteria, yeast, parasites, fungus, viruses, and the like. More specifically, specificity exchangers can redirect existing antibodies in a subject to pathogens and cancer cells.
摘要翻译：公开了制备和使用特异性交换剂的特异性交换剂和方法。特异性交换剂可用于预防和治疗包括癌症在内的人类疾病以及由细菌，酵母，寄生虫，真菌，病毒等病原体引起的疾病。更具体地，特异性交换剂可以将受试者中的现有抗体重定向于病原体和癌细胞。

2. 发明授权

US06933366B2 Specificity exchangers that redirect antibodies to bacterial adhesion receptors 失效
标题翻译：将抗体转向细菌粘附受体的特异性交换剂
公开(公告)号：US06933366B2
公开(公告)日：2005-08-23
申请号：US10372735
申请日：2003-02-21
申请人： Matti Sallberg , Jan-Ingmar Flock
发明人： Matti Sallberg , Jan-Ingmar Flock
IPC分类号： A61K38/00 , C07K7/06 , C07K7/08 , C07K14/02 , C07K14/025 , C07K14/16 , C07K14/18 , C07K14/195 , C07K14/78 , C07K16/00 , C07K16/08 , C07K16/10 , C07K19/00 , G01N33/531 , G01N33/569 , C07K1/00
CPC分类号： C07K7/06 , A61K38/00 , A61K2039/505 , C07K7/08 , C07K14/005 , C07K14/195 , C07K14/75 , C07K14/78 , C07K16/00 , C07K16/082 , C07K16/087 , C07K16/1009 , C07K16/1063 , C07K16/109 , C07K19/00 , C07K2317/50 , C07K2317/565 , C07K2317/73 , C07K2318/10 , C12N2710/16622 , C12N2710/20022 , C12N2730/10122 , C12N2740/16222 , C12N2770/24222 , C12N2770/32622 , G01N33/531 , G01N33/569 , Y02A50/466
摘要： Specificity exchangers and methods of making and using specificity exchangers are disclosed. Specificity exchangers are useful for preventing and treating human diseases including cancer and those resulting from pathogens such as bacteria, yeast, parasites, fungus, viruses, and the like. More specifically, specificity exchangers can redirect existing antibodies in a subject to pathogens and cancer cells.
摘要翻译：公开了制备和使用特异性交换剂的特异性交换剂和方法。特异性交换剂可用于预防和治疗包括癌症在内的人类疾病以及由细菌，酵母，寄生虫，真菌，病毒等病原体引起的疾病。更具体地，特异性交换剂可以将受试者中的现有抗体重定向于病原体和癌细胞。

3. 发明申请

US20060094862A1 Specificity exchangers that redirect antibodies to a pathogen 审中-公开
公开(公告)号：US20060094862A1
公开(公告)日：2006-05-04
申请号：US11121282
申请日：2005-05-03
申请人： Matti Sallberg , Jan-Ingmar Flock
发明人： Matti Sallberg , Jan-Ingmar Flock
IPC分类号： C07K14/195
摘要： Specificity exchangers and methods of making and using specificity exchangers are disclosed. Specificity exchangers are useful for preventing and treating human diseases including cancer and those resulting from pathogens such as bacteria, yeast, parasites, fungus, viruses, and the like. More specifically, specificity exchangers can redirect existing antibodies in a subject to pathogens and cancer cells.

4. 发明申请

US20160251400A1 HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY 审中-公开
标题翻译：用于重定向抗体特异性的高亲和力分子
公开(公告)号：US20160251400A1
公开(公告)日：2016-09-01
申请号：US15013773
申请日：2016-02-02
申请人： Albert Collinson , Peter Wagner , Matti Sallberg , Anders Vahlne , Gregor Schurmann , Robert Kamen
发明人： Albert Collinson , Peter Wagner , Matti Sallberg , Anders Vahlne , Gregor Schurmann , Robert Kamen
IPC分类号： C07K14/00 , C12N15/10
CPC分类号： C07K14/00 , C12N15/1062 , C40B30/04 , C40B40/08 , C40B50/06
摘要： Disclosed are methods for identifying high affinity adaptor molecules that bind to both a circulating antibody and a target molecule and redirect the specificity of the circulating antibody to the target molecule. Exemplary high affinity adaptor molecules are also provided.
摘要翻译：公开了用于鉴定结合循环抗体和靶分子并将循环抗体的特异性重定向到靶分子的高亲和性衔接子分子的方法。还提供了示例性的高亲和性衔接子分子。

5. 发明申请

US20140121587A1 INJECTION NEEDLE AND DEVICE 有权
标题翻译：注射针和装置
公开(公告)号：US20140121587A1
公开(公告)日：2014-05-01
申请号：US14125905
申请日：2012-06-13
申请人： Matti Sallberg , Lars Frelin
发明人： Matti Sallberg , Lars Frelin
IPC分类号： A61N1/30
CPC分类号： A61N1/0502 , A61K9/0019 , A61K39/29 , A61K2039/53 , A61K2039/54 , A61M5/3291 , A61M5/3298 , A61M5/46 , A61N1/306 , A61N1/327 , C12M35/02 , C12N7/00 , C12N2730/10134 , C12N2770/24234
摘要： Several needle assemblies and intracellular delivery devices that are used for the delivery of prophylactic and/or therapeutic material (i.e., delivered agents) into a tissue of a subject are disclosed. Preferably, the needle assemblies and/or the intracellular delivery devices comprise needles and/or needle electrodes, which are disposed in an array (e.g., a Y-type array having three outer needles and a center needle), wherein each needle in the array has a closed end and a plurality of apertures along each needle barrel, and the apertures on the needle barrels of the outer needles of the array are positioned to deliver the delivered agent toward the apertures of the center needle and/or an adjacent needle, but not outside of the active zone defined by the area within the needle array and the apertures on the needle barrel of the center needle are positioned to deliver the delivered agent toward the outer needles.
摘要翻译：公开了用于将预防和/或治疗材料（即递送的试剂）递送到受试者的组织中的几个针组件和细胞内递送装置。优选地，针组件和/或细胞内递送装置包括排列成阵列的针和/或针电极（例如，具有三个外针和中心针的Y型阵列），其中阵列中的每个针具有围绕每个针筒的封闭端和多个孔，并且阵列的外针的针筒上的孔定位成将输送的药剂输送到中心针和/或相邻针的孔，但是不在由针阵列内的区域限定的活动区域的外侧，并且中心针的针筒上的孔定位成将输送的药剂朝向外针输送。

6. 发明授权

US08163547B2 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene 有权
公开(公告)号：US08163547B2
公开(公告)日：2012-04-24
申请号：US12894004
申请日：2010-09-29
申请人： Matti Sallberg
发明人： Matti Sallberg
IPC分类号： C12N15/51 , A61K39/29
CPC分类号： C07K14/005 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/29 , A61K39/39 , A61K2039/53 , A61K2039/55505 , A61K2039/55511 , A61K2039/57 , A61K2121/00 , A61K2123/00 , C12N7/00 , C12N2730/10134 , C12N2770/24022 , C12N2770/24221 , C12N2770/24222 , C12N2770/24234 , C12N2800/22 , Y02A90/22 , Y02A90/26 , A61K2300/00
摘要： Aspects of the present invention relate to the discovery of a novel hepatitis C virus (HCV) isolate. Embodiments include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.

7. 发明申请

US20110081381A1 HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE 有权
公开(公告)号：US20110081381A1
公开(公告)日：2011-04-07
申请号：US12894014
申请日：2010-09-29
申请人： Matti Sallberg
发明人： Matti Sallberg
IPC分类号： A61K39/29 , A61P31/14
CPC分类号： C07K14/005 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/29 , A61K39/39 , A61K2039/53 , A61K2039/55505 , A61K2039/55511 , A61K2039/57 , A61K2121/00 , A61K2123/00 , C12N7/00 , C12N2730/10134 , C12N2770/24022 , C12N2770/24221 , C12N2770/24222 , C12N2770/24234 , C12N2800/22 , Y02A90/22 , Y02A90/26 , A61K2300/00
摘要： Aspects of the present invention relate to the discovery of a novel hepatitis C virus (HCV) isolate. Embodiments include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.

8. 发明申请

US20060276621A1 Glycosylated specificity exchangers 有权
公开(公告)号：US20060276621A1
公开(公告)日：2006-12-07
申请号：US11411454
申请日：2006-04-26
申请人： Matti Sallberg
发明人： Matti Sallberg
IPC分类号： C07K14/00 , C07K16/00 , A61K38/00 , C07K17/00 , C07K2/00 , C07K4/00 , C07K5/00 , C07K7/00
CPC分类号： C07K16/30 , A61K2039/505 , C07K9/00 , C07K14/005 , C07K14/47 , C07K14/705 , C07K14/70514 , C07K14/75 , C07K16/00 , C07K2317/41 , C07K2317/565 , C07K2319/00
摘要： The present invention is directed to ligand/receptor and antigen/antibody specificity exchangers comprising a saccharide or glycoconjugate. Methods of making these specificity exchangers and methods of using said specificity exchangers to treat or prevent human disease are described herein.

9. 发明申请

US20060062801A1 Hepatitis C virus non-structural NS3/4A fusion gene 有权
标题翻译：丙型肝炎病毒非结构NS3 / 4A融合基因
公开(公告)号：US20060062801A1
公开(公告)日：2006-03-23
申请号：US11249893
申请日：2005-10-13
申请人： Matti Sallberg
发明人： Matti Sallberg
IPC分类号： A61K39/29 , A61K48/00 , C07K14/18
CPC分类号： A61K39/29 , A01K67/0271 , A61K31/7056 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/39 , A61K2039/53 , A61K2039/545 , A61K2039/55505 , A61K2039/55511 , A61K2039/57 , A61K2121/00 , A61K2123/00 , C07K14/005 , C07K16/109 , C12N7/00 , C12N2740/16134 , C12N2770/24022 , C12N2770/24221 , C12N2770/24222 , C12N2770/24234 , G06F19/00 , G06Q50/22 , Y02A50/464 , Y02A90/22 , Y02A90/26
摘要： Disclosed herein is the discovery of a novel hepatitis C virus (HCV) isolated from a human patient. Embodiments of the inevntion include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as, methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.
摘要翻译：本文公开了从人类患者分离的新型丙型肝炎病毒（HCV）的发现。不可避免的实施方案包括HCV肽，编码所述HCV肽的核酸，针对所述肽的抗体，含有所述核酸和肽的组合物，以及制备和使用上述组合物的方法，包括但不限于诊断和用于治疗和预防HCV感染的药物。

10. 发明申请

US20050124573A1 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene 有权
标题翻译：丙型肝炎病毒密码子优化非结构NS3 / 4A融合基因
公开(公告)号：US20050124573A1
公开(公告)日：2005-06-09
申请号：US11043808
申请日：2005-01-25
申请人： Matti Sallberg
发明人： Matti Sallberg
IPC分类号： A61K38/00 , A61K39/00 , A61K39/29 , A61K39/39 , C07K14/18 , C12N5/02 , C12N7/00 , C12N15/40 , A61K48/00 , A61K31/7056
CPC分类号： C07K14/005 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/29 , A61K39/39 , A61K2039/53 , A61K2039/55505 , A61K2039/55511 , A61K2039/57 , A61K2121/00 , A61K2123/00 , C12N7/00 , C12N2730/10134 , C12N2770/24022 , C12N2770/24221 , C12N2770/24222 , C12N2770/24234 , C12N2800/22 , Y02A90/22 , Y02A90/26 , A61K2300/00
摘要： Aspects of the present invention relate to the discovery of a novel hepatitis C virus (HCV) isolate. Embodiments include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.
摘要翻译：本发明的方面涉及新型丙型肝炎病毒（HCV）分离株的发现。实施方案包括HCV肽，编码所述HCV肽的核酸，针对所述肽的抗体，含有所述核酸和肽的组合物，以及制备和使用上述组合物的方法，包括但不限于用于治疗的诊断和药物并预防HCV感染。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式